ABSTRACT
AIMS: Intermittent catheters (ICs) are commonly used in bladder management, but catheter-associated urinary tract infections (CAUTIs) remain challenging. Insertion tips may reduce the risk of CAUTIs by minimizing bacterial transfer along the urinary tract. However, there are few laboratory tests to evaluate such technologies. We describe the use of an adapted in vitro urethra agar model to assess bacterial displacement by ICs. METHODS AND RESULTS: Simulated urethra agar channels (UACs) were prepared with catheter-specific sized channels in selective media specific to the challenge organisms. UACs were inoculated with Escherichia coli and Enterococcus faecalis before insertion of ICs, and enumeration of UAC sections was performed following insertion. Four ICs were evaluated: Cure Catheter® Closed System (CCS), VaPro Plus Pocket™, Bard® Touchless® Plus, and SpeediCath® Flex Set. CCS demonstrated significantly reduced bacterial displacement along the UACs compared to the other ICs and was also the only IC with undetectable levels of bacteria toward the end of the UAC (representing the proximal urethra). CONCLUSION: The bacterial displacement test demonstrated significant differences in bacterial transfer between the test ICs with insertion tips, which may reflect their different designs. This method is useful for evaluating CAUTI prevention technology and may help guide future technology innovations.
Subject(s)
Enterococcus faecalis , Escherichia coli , Urinary Tract Infections , Urinary Tract Infections/microbiology , Urinary Tract Infections/prevention & control , Urinary Tract Infections/diagnosis , Humans , Escherichia coli/isolation & purification , Enterococcus faecalis/isolation & purification , Urinary Catheters/microbiology , Catheter-Related Infections/microbiology , Catheter-Related Infections/prevention & control , Catheter-Related Infections/diagnosis , Urinary Catheterization/instrumentation , Urinary Catheterization/adverse effects , Urethra/microbiologyABSTRACT
PURPOSE: About 50% of individuals with long-term indwelling catheters are affected by catheter encrustations and bladder stone formation. Therefore, prophylaxis of catheter encrustations is important. Currently, however, neither an established prophylaxis nor a standardized in-vitro model to test different measures exist. We have therefore developed and qualitatively evaluated an in-vitro model of catheter encrustation. METHODS: Size 14 French suprapubic catheters were incubated under sterile conditions at 37 degrees Celsius in five different media: (1) sterile artificial urine (n = 16), (2) artificial urine with E. coli (n = 8), (3) with Pseudomonas aeruginosa (n = 8), (4) with Proteus mirabilis (n = 8), and (5) with a mix of these three strains (n = 8). Catheter balloons were inflated either a glycerine or a bactericidal solution. After 6 weeks, the catheters were removed from the solution, dried, and weighed, and a photometric determination of the retrieved encrustations was performed. RESULTS: Most frequently and pronounced encrustations were detected in the Pseudomonas group. The median weight of these encrustations (50% struvite and brushite) was 84.4 mg (47.7 mg / 127.3 mg). Even on catheters stored in sterile urine, encrustations (69.2% struvite) were found. Bacterial growth was not affected by the medium used for catheter blockage. CONCLUSION: Although in-vitro models appear to be limited because they lack "the human factor", they are valuable for systematically assessing physico-chemical factors affecting encrustations. Therefore, our model, being reliable and cost-effective, may foster further research despite its limitations.
Subject(s)
Urinary Catheters , Humans , Urinary Catheters/microbiology , Urinary Catheters/adverse effects , Catheters, Indwelling/microbiology , Catheters, Indwelling/adverse effects , Proteus mirabilis/isolation & purification , Pseudomonas aeruginosa , In Vitro Techniques , Catheter-Related Infections/prevention & control , Catheter-Related Infections/microbiology , Escherichia coli , Urinary Catheterization/adverse effects , Urinary Catheterization/instrumentation , Models, BiologicalABSTRACT
The bacterium Escherichia coli is one of the main causes of urinary tract infections. The formation of bacterial biofilms, especially associated with the use of urinary catheters, contributes to the establishment of recurrent infections and the development of resistance to treatment. Strains of E. coli that produce extended-spectrum beta-lactamases (ESBL) have a greater ability to form biofilms. In addition, there is a lack of drugs available in the market with antibiofilm activity. Promethazine (PMZ) is an antihistamine known to have antimicrobial activity against different pathogens, including in the form of biofilms, but there are still few studies of its activity against ESBL E. coli biofilms. The aim of this study was to evaluate the antimicrobial activity of PMZ against ESBL E. coli biofilms, as well as to assess the application of this drug as a biofilm prevention agent in urinary catheters. To this end, the minimum inhibitory concentration and minimum bactericidal concentration of PMZ in ESBL E. coli strains were determined using the broth microdilution assay and tolerance level measurement. The activity of PMZ against the cell viability of the in vitro biofilm formation of ESBL E. coli was analyzed by the MTT colorimetric assay and its ability to prevent biofilm formation when impregnated in a urinary catheter was investigated by counting colony-forming units (CFU) and confirmed by scanning electron microscopy (SEM). PMZ showed bactericidal activity and significantly reduced (p < 0.05) the viability of the biofilm being formed by ESBL E. coli at concentrations of 256 and 512 µg/ml, as well as preventing the formation of biofilm on urinary catheters at concentrations starting at 512 µg/ml by reducing the number of CFUs, as also observed by SEM. Thus, PMZ is a promising candidate to prevent the formation of ESBL E. coli biofilms on abiotic surfaces.
Subject(s)
Anti-Bacterial Agents , Biofilms , Escherichia coli , Microbial Sensitivity Tests , Promethazine , Urinary Catheters , beta-Lactamases , Biofilms/drug effects , Biofilms/growth & development , Promethazine/pharmacology , Escherichia coli/drug effects , beta-Lactamases/metabolism , Urinary Catheters/microbiology , Anti-Bacterial Agents/pharmacology , Humans , Urinary Tract Infections/microbiology , Microbial Viability/drug effects , Escherichia coli Infections/microbiology , Escherichia coli Infections/drug therapyABSTRACT
Catheter-associated urinary tract infections represent a major share of nosocomial infections, and are associated with longer periods of hospitalization and a huge financial burden. Currently, there are only a handful of commercial materials that reduce biofilm formation on urinary catheters, mostly relying on silver alloys. Therefore, we combined silver-phenolated lignin nanoparticles with poly(carboxybetaine) zwitterions to build a composite antibiotic-free coating with bactericidal and antifouling properties. Importantly, the versatile lignin chemistry enabled the formation of the coating in situ, enabling both the nanoparticle grafting and the radical polymerization by using only the oxidative activity of laccase. The resulting surface efficiently prevented nonspecific protein adsorption and reduced the bacterial viability on the catheter surface by more than 2 logs under hydrodynamic flow, without exhibiting any apparent signs of cytotoxicity. Moreover, the said functionality was maintained over a week both in vitro and in vivo, whereby the animal models showed excellent biocompatibility.
Subject(s)
Laccase , Urinary Catheters , Urinary Catheters/microbiology , Animals , Laccase/chemistry , Silver/chemistry , Silver/pharmacology , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Lignin/chemistry , Mice , Humans , Biofilms/drug effects , Urinary Tract Infections/prevention & control , Urinary Tract Infections/drug therapy , Escherichia coli/drug effects , Nanoparticles/chemistry , Staphylococcus aureus/drug effectsABSTRACT
<b>Background and Objective:</b> Urinary tract infections from the use of an indwelling urinary catheter are one of the most common infections caused by <i>Proteus mirabilis</i>. Due to their biofilm-producing capacity and the increasing antimicrobial resistance in this microorganism, this study aimed to determine the prevalence, biofilm-producing capacity, antimicrobial resistance patterns, multidrug resistance and plasmid mediated resistance of the recovered isolates. <b>Materials and Methods:</b> A total of 50 urinary samples were collected from May to August, 2018 from patients on indwelling urinary catheters. Using routine microbiological and biochemical methods, 37 <i>P. mirabilis</i> were isolated. Biofilm forming capability was determined among the isolates using the tube method while antimicrobial susceptibility and plasmid curing were also performed. <b>Results:</b> All isolates were biofilm producers with 17(46%) being moderate producers while 20(54%) were strong biofilm formers. The study isolates exhibited a high resistance rate to empiric antibiotics, including ceftazidime (75.8%), cefuroxime (54.5%), ampicillin (69.7%) and amoxicillin-clavulanic acid (51.5%). Low resistance was seen in the fluoroquinolones, gentamicin and nitrofurantoin. Plasmid curing experiment revealed that most isolates lost their resistance indicating that resistance was borne on plasmids. Plasmid carriage is likely the reason for the high MDR rate of 56.8% observed. <b>Conclusion:</b> These findings necessitate the provision of infection control programs which will guide and implement policies.
Subject(s)
Anti-Bacterial Agents , Biofilms , Catheters, Indwelling , Microbial Sensitivity Tests , Proteus mirabilis , Biofilms/drug effects , Biofilms/growth & development , Proteus mirabilis/drug effects , Proteus mirabilis/genetics , Proteus mirabilis/isolation & purification , Catheters, Indwelling/microbiology , Catheters, Indwelling/adverse effects , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Urinary Tract Infections/microbiology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/diagnosis , Plasmids/genetics , Urinary Catheters/microbiology , Urinary Catheters/adverse effects , Drug Resistance, Bacterial , Proteus Infections/microbiology , Proteus Infections/drug therapy , Catheter-Related Infections/microbiology , Catheter-Related Infections/diagnosis , Catheter-Related Infections/drug therapy , Female , Male , Drug Resistance, Multiple, Bacterial/geneticsABSTRACT
Catheter-associated urinary tract infections are the most common hospital-acquired infections and cause patient discomfort, increased morbidity, and prolonged stays, altogether posing a huge burden on healthcare services. Colonization occurs upon insertion, or later by ascending microbes from the rich periurethral flora, and is therefore virtually unavoidable by medical procedures. Importantly, the dwell time is a significant risk factor for bacteriuria because it gives biofilms time to develop and mature. This is why we engineer antibacterial and antibiofilm coating through ultrasound- and nanoparticle-assisted self-assembly on silicone surfaces and validate it thoroughly in vitro and in vivo. To this end, we combine bimetallic silver/gold nanoparticles, which exercise both biocidal and structural roles, with dopamine-modified gelatin in a facile and substrate-independent sonochemical coating process. The latter mussel-inspired bioadhesive potentiates the activity and durability of the coating while attenuating the intrinsic toxicity of silver. As a result, our approach effectively reduces biofilm formation in a hydrodynamic model of the human bladder and prevents bacteriuria in catheterized rabbits during a week of placement, outperforming conventional silicone catheters. These results substantiate the practical use of nanoparticle-biopolymer composites in combination with ultrasound for the antimicrobial functionalization of indwelling medical devices.
Subject(s)
Anti-Bacterial Agents , Biofilms , Nanocomposites , Silver , Urinary Tract Infections , Animals , Rabbits , Urinary Tract Infections/prevention & control , Silver/chemistry , Silver/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Nanocomposites/chemistry , Biofilms/drug effects , Humans , Metal Nanoparticles/chemistry , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Gold/chemistry , Bivalvia/chemistry , Urinary Catheters/microbiology , Gelatin/chemistry , Gelatin/pharmacology , Escherichia coli/drug effects , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiologyABSTRACT
The presence of a variety of bacteria is an inevitable/indispensable part of human life. In particular, for patients, the existence and spreading of bacteria lead to prolonged treatment period with many more complications. The widespread use of urinary catheters is one of the main causes for the prevalence of infections. The necessity of long-term use of indwelling catheters is unavoidable in terms of the development of bacteriuria and blockage. As is known, since a permanent solution to this problem has not yet been found, research and development activities continue actively. Herein, polyethylene glycol (PEG)-like thin films were synthesized by a custom designed plasma enhanced chemical vapor deposition (PE-CVD) method and the long-term effect of antifouling properties of PEG-like coated catheters was investigated against Escherichia coli and Proteus mirabilis. The contact angle measurements have revealed the increase of wettability with the increase of plasma exposure time. The antifouling activity of surface-coated catheters was analyzed against the Gram-negative/positive bacteria over a long-term period (up to 30 days). The results revealed that PE-CVD coated PEG-like thin films are highly capable of eliminating bacterial attachment on surfaces with relatively reduced protein attachment without having any toxic effect. Previous statements were supported with SEM, XPS, FTIR spectroscopy, and contact angle analysis.
Subject(s)
Escherichia coli , Polyethylene Glycols , Proteus mirabilis , Surface Properties , Urinary Catheters , Urinary Catheters/microbiology , Escherichia coli/drug effects , Proteus mirabilis/drug effects , Polyethylene Glycols/chemistry , Bacterial Adhesion/drug effects , Biofouling/prevention & control , Humans , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacologyABSTRACT
Catheter-associated urinary tract infections (CAUTIs) pose a significant challenge in hospital settings. Current solutions available on the market involve incorporating antimicrobials and antiseptics into catheters. However, challenges such as uncontrolled release leading to undesirable toxicity, as well as the prevalence of antimicrobial resistance reduce the effectiveness of these solutions. Additionally, conventional antibiotics fail to effectively eradicate entrenched bacteria and metabolically suppressed bacteria present in the biofilm, necessitating the exploration of alternative strategies. Here, we introduce a novel polymer-nanocomposite coating that imparts rapid antimicrobial and anti-biofilm properties to coated urinary catheters. We have coated silicone-based urinary catheters with an organo-soluble antimicrobial polymer nanocomposite (APN), containing hydrophobic quaternized polyethyleneimine and zinc oxide nanoparticles, in a single step coating process. The coated surfaces exhibited rapid eradication of drug-resistant bacteria within 10-15 min, including E. coli, K. pneumoniae, MRSA, and S. epidermidis, as well as drug-resistant C. albicans fungi. APN coated catheters exhibited potent bactericidal activity against uropathogenic strains of E. coli, even when incubated in human urine. Furthermore, the stability of the coating and retention of antimicrobial activity was validated even after multiple washes. More importantly, this coating deterred biofilm formation on the catheter surface, and displayed rapid inactivation of metabolically repressed stationary phase and persister cells. The ability of the coated surfaces to disrupt bacterial membranes and induce the generation of intracellular reactive oxygen species (ROS) was assessed through different techniques, such as electron microscopy imaging, flow cytometry as well as fluorescence spectroscopy and microscopy. The surface coatings were found to be biocompatible in an in vivo mice model. Our simple one-step coating approach for catheters holds significant potential owing to its ability to tackle multidrug resistant bacteria and fungi, and the challenge of biofilm formation. This work brings us one step closer to enhancing patient care and safety in hospitals.
Subject(s)
Biofilms , Nanocomposites , Urinary Catheters , Urinary Tract Infections , Nanocomposites/chemistry , Urinary Tract Infections/prevention & control , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Animals , Biofilms/drug effects , Humans , Mice , Urinary Catheters/microbiology , Catheter-Related Infections/prevention & control , Catheter-Related Infections/microbiology , Candida albicans/drug effects , Escherichia coli/drug effects , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Zinc Oxide/chemistry , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Polyethyleneimine/chemistry , Microbial Sensitivity TestsABSTRACT
Bacteria can swim upstream in a narrow tube and pose a clinical threat of urinary tract infection to patients implanted with catheters. Coatings and structured surfaces have been proposed to repel bacteria, but no such approach thoroughly addresses the contamination problem in catheters. Here, on the basis of the physical mechanism of upstream swimming, we propose a novel geometric design, optimized by an artificial intelligence model. Using Escherichia coli, we demonstrate the anti-infection mechanism in microfluidic experiments and evaluate the effectiveness of the design in three-dimensionally printed prototype catheters under clinical flow rates. Our catheter design shows that one to two orders of magnitude improved suppression of bacterial contamination at the upstream end, potentially prolonging the in-dwelling time for catheter use and reducing the overall risk of catheter-associated urinary tract infection.
Subject(s)
Urinary Catheters , Urinary Tract Infections , Humans , Urinary Catheters/microbiology , Artificial Intelligence , Urinary Tract Infections/prevention & control , Urinary Tract Infections/microbiology , Bacteria , Escherichia coli , HydrolasesABSTRACT
Over the past decade, superhydrophilic zwitterionic surfaces, slippery liquid-infused porous surfaces, covalently attached liquid-like surfaces, and superhydrophobic surfaces have emerged as the most promising strategies to prevent biofouling on biomedical devices. Despite working through different mechanisms, they have demonstrated superior efficacy in preventing the adhesion of biomolecules (e.g., proteins and bacteria) compared with conventional material surfaces. However, their potential in combating catheter-associated urinary tract infection (CAUTI) remains uncertain. In this research, we present the fabrication of these four coatings for urinary catheters and conduct a comparative assessment of their antifouling properties through a stepwise approach. Notably, the superhydrophilic zwitterionic coating demonstrated the highest antifouling activity, reducing 72.3% of fibrinogen deposition and over 75% of bacterial adhesion (Escherichia coli and Staphylococcus aureus) when compared with an uncoated polyvinyl chloride (PVC) surface. The zwitterionic coating also exhibited robust repellence against blood and improved surface lubricity, decreasing the dynamic coefficient of friction from 0.63 to 0.35 as compared with the PVC surface. Despite the fact that the superhydrophilic zwitterionic and hydrophobic liquid-like surfaces showed great promise in retarding crystalline biofilm formation in the presence of Proteus mirabilis, it is worth noting that their long-term antifouling efficacy may be compromised by the proliferation and migration of colonized bacteria as they are unable to kill them or inhibit their swarming. These findings underscore both the potential and limitations of these ultralow fouling materials as urinary catheter coatings for preventing CAUTI.
Subject(s)
Biofouling , Urinary Tract Infections , Humans , Urinary Tract Infections/prevention & control , Urinary Catheters/adverse effects , Urinary Catheters/microbiology , Biofouling/prevention & control , Escherichia coli , Bacteria , Hydrophobic and Hydrophilic InteractionsABSTRACT
Objetive: To evaluate colonizations on biofilm layers of Double J (D-J) catheters implanted for kidney stones or ureteral stones under sterile conditions. Methods: -J catheters implanted between January 2012 and February 2014 and removed in 0-90 days, were examined in microbiology laboratory prospectively. Fifty two patients divided into three groups regarding the duration of the D-J catheters as; 0-30 days, 31-60 days, 61-90 days. The colonization (≥1.000 colony) was reported after biofilm layer on D-J catheter was hold in culture media. The upper, middle and lower parts of the catheters were analyzed seperately. Results:Thirty five patients had symptomatic urinary tract infection or positive urine culture after implantation were excluded from the study. Colonization on biofilm layer was detected in 11 patients (21.15%) [Coagulase-negative staphylococci (CNS): 3, Escherichia coli (E. coli): 3, Candida species (Candida spp.): 3, Klebsiella species (Klebsiella spp.): 2]. The rates of colonization according to the duration of the catheterization were; 12.5% in 0-30 days, 18.51% in 30-60 days, 29.4% in 60-90 days (Group 1 vs 2; p=0.696 , group 1 vs group 3; p=0.356 , group 2 vs group 3; p=0.401). The rates of colonization according to the location of the catheter were; 100% in upper and lower parts, 54.4% in middle part (Group 1 vs 2; p=0.011, group 1 vs group 3; p=1, group 2 vs group 3; p=0.011). Conclusions: Colonization on catheters is possible even in the sterile urinary conditions according to the present findings. The risk of colonization increases 1.5 times in 30-60 days and 2.5 times in 60-90 days compared to the first 30 days. Besides the risk of colonization increases about 2 times in the convoluted edges of the catheter compared with the middle part. Thus, D-J catheter should be removed as soon as possible and the risk of colonization should be minimalized
Objetivo: Evaluar la colonización de las capas de biofilm de los catéteres doble J (DJ) implantados por litiasis renal o ureteral bajo condiciones estériles. Métodos: Los catéteres DJ implantados entre enero 2012 y febrero 2014 y retirados en 0-90 días fueron examinados de forma prospectiva en el laboratorio de microbiología. Cincuenta y dos pacientes fueron divididos en tres grupos conforme al tiempo del DJ: 0-30 días, 31-60 días y 61-90 días. La colonización (>100.000 colonias) fue comunicada tras el cultivo de la capa de biofilm del catéter. Se analizaron por separado las zonas superior, media e inferior de los catéteres DJ. Resultados: 35 pacientes que tenían infección urinaria sintomática o cultivo de orina positivo después del implante fueron excluidos del estudio. Se detectó colonización de la capa de biofilm en 11 pacientes (21,5%) [estafilococo coagulasa negativo (SCN): 3, Escherichia coli (E.coli): 3, Cándida especies (Cándida spp: 3, Klebsiela especies (Klebsiela spp.): 2] Las tasas de colonización de acuerdo con el tiempo de catéter fueron 12,5% en 0-30 días, 18,51% en 30-60 días, 29,4% en 60-90 días (Grupo 1 vs 2; ,696 , grupo 1 vs grupo 3; ,356, grupo 2 vs grupo 3; ,401). Las tasas de colonización de acuerdo con la localización del catéter fueron del 100% en las porciones superior e inferior y 54% en la porción media (Grupo 1 vs 2; ,011, grupo 1 vs grupo 3; , grupo 2 vs grupo 3; ,011). Conclusiones: La colonización de los catéteres es posible incluso en condiciones de orina estéril de acuerdo con los hallazgos presentes. El riesgo de colonización aumenta 1,5 veces en 30-60 días y 2,5 veces en 60-90 días comparado con los primeros 30 días. Además, el riesgo de colonización aumenta unas 2 veces en los extremos espirales del catéter en comparación con la porción media. Así, los catéteres DJ deben ser retirados tan pronto como sea posible y el riesgo de colonización debe ser minimizado
Subject(s)
Humans , Biofilms , Catheterization , Escherichia coli/isolation & purification , Urinary Catheters/microbiology , Escherichia coli Infections/microbiologyABSTRACT
Resumo Objetivo: Avaliar a influência do tempo de exposição e calibre na formação de biofilme em cateteres urinários de Foley (CUFs). Método: Pesquisa in vitro com amostras de fragmentos de CUFs em látex siliconizado de diferentes calibres (n° 14 e n° 16 Frenchs). A urina artificial foi confeccionada, inoculada com bactérias-padrão Staphylococcus aureus (ATCC 25923) e Pseudomonas aeruginosa (ATCC 27853) e incubada a 37 °C por 24 horas e 72 horas. As análises foram realizadas por meio de cultura (carga bacteriana) e microscopia eletrônica de varredura. Resultados: Não houve diferença na carga bacteriana dos biofilmes formados nas superfícies dos CUFs com relação aos diferentes calibres (p > 0,05). Por outro lado, o tempo de exposição (24 horas e 72 horas) foi o fator determinante para formação do biofilme de P. aeruginosa nos CUFs (p < 0,05). Conclusão: O tempo de exposição influenciou a formação do biofilme de P. aeruginosa nos CUFs, independentemente dos calibres.
Resumen Objetivo: Evaluar la influencia del tiempo de exposición y calibre en la formación de biofilm en catéteres urinarios de Foley (CUFs). Método: Investigación in vitro con muestras de fragmentos de CUFs en látex siliconizado de diferentes calibres (n ° 14 y n° 16 Frenchs). La orina artificial fue confeccionada, inoculada con bacterias estándar Staphylococcus aureus (ATCC 25923) y Pseudomonas aeruginosa (ATCC 27853) e incubada a 37 °C durante 24 horas y 72 horas. Los análisis se realizaron por medio de cultivo (carga bacteriana) y microscopía electrónica de exploración. Resultados: No hubo diferencia en la carga bacteriana de los biofilmes formados en las superficies de los CUFs en relación con los diferentes calibres (p> 0,05). Por otro lado, el tiempo de exposición (24 horas y 72 horas) fue el factor determinante para la formación del biofilm de P. aeruginosa en los CUFs (p <0,05). Conclusión: El tiempo de exposición influenció la formación del biofilm de P. aeruginosa en los CUFs, independientemente de los calibres.
Abstract Objective: To assess the effects of exposure time and gauge of Foley catheters in biofilm formation. Method: In vitro study with samples of Foley catheter fragments made of siliconized latex of different gauges (#14 and #16 French gauge). Artificial urine was produced, which was inoculated with Staphylococcus aureus (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853) standard bacteria, incubated at 37 °C for 24 hours and 72 hours. The material was analyzed by means of culture (bacterial load) and scanning electron microscopy. Results: There was no difference in bacterial load of biofilms formed in Foley catheter surfaces with regard to different gauges (p > 0.05). On the other hand, exposure time (24 hours and 72 hours) was a determining factor for P. aeruginosa biofilm formation in Foley catheters (p < 0.05). Conclusion: Exposure time had an effect on P. aeruginosa biofilm formation in Foley catheters, regardless of gauges.
Subject(s)
Pseudomonas aeruginosa , Staphylococcus aureus , Urinary Tract Infections/microbiology , Biofilms , Bacterial Load , Urinary Catheters/microbiology , In Vitro Techniques , Microscopy, Electron, Scanning , Culture MediaABSTRACT
Objetivo: Determinar la incidencia de infección del tracto urinario en los pacientes en los que hemos utilizado un catéter ureteral doble J como desvío interno después de procedimientos urológicos. Material y métodos: Se revisaron todas las historias clínicas de los pacientes que tenían un catéter ureteral doble J después de un procedimiento urológico desde agosto de 2007 hasta mayo de 2013. Hemos analizado los siguientes datos: edad, sexo, tipo de profilaxis, incidencia de la infección del tracto urinario (ITU), días de desviación interna con catéter doble J, procedimiento quirúrgico, características bacterianas, sensibilidad de las bacterias a los antibióticos y tratamiento de ITU. Resultados: Hemos utilizado 73 catéteres doble J como desvío interno ureteral en 67 pacientes con una edad media de 44,73 ± 57,23. Los procedimientos quirúrgicos fueron 50 pieloplastias laparoscópicas Anderson-Hynes en 49 pacientes y 20 dilataciones con balón de alta presión de la unión ureterovesical para tratar megauréter obstructivo primario en 15 pacientes, y 3 pacientes con obstrucción ureterovesical después del tratamiento endoscópico del reflujo vesicoureteral. Cuarenta y tres catéteres mostraron una colonización bacteriana en los cultivos. Pseudomona aeruginosa estaba presente en 9 (20,9%) catéteres. Solo en 12 catéteres la colonización bacteriana era sensible a la profilaxis antibiótica. La colonización del catéter era mayor en los niños y los pacientes más jóvenes. Cuatro pacientes tuvieron una ITU febril. La incidencia de ITU en los pacientes más jóvenes que se sometieron a DBAP de UUV es mayor. Conclusión: La colonización bacteriana es frecuente en los catéteres doble J, pero la incidencia de ITU es baja. La colonización doble J es mayor en los pacientes más jóvenes. Los pacientes que se sometieron a DBAP tienen un mayor riesgo de ITU relacionada con el catéter ureteral doble J
Objective: To determine the incidence of urinary tract infection in those patients that we have used an ureteral double-J stent as internal diversion after urological procedures. Material and methods: We reviewed all the medical records of patients who had a ureteral double-J stent after a urological procedure from August 2007 to May 2013. We have analyzed the following data: age, gender, type of prophylaxis, incidence of urinary tract infection (UTI), days of internal diversion with double-J stent, surgical procedure, bacterial characteristics, bacterial sensibility to antibiotics and UTI treatment. Results: We have used 73 double-J stents as ureteral internal diversion in 67 patients with a mean age of 44.73 ± 57.23. Surgical procedures were 50 laparoscopic Anderson-Hynes pyeloplasties in 49 patients, and 20 high-pressure balloon dilatation of the ureterovesical junction to treat primary obstructive megaureter in 15 patients; and 3 patients with ureterovesical obstruction after endoscopic treatment of vesicoureteral reflux. Forty three stents showed a bacterial colonization in cultures. Pseudomona aeruginosa was present in 9 (20.9%) stents. Only in 12 stents, bacterial colonization was sensible to antibiotic prophylaxis. Stent colonization was higher in boys and younger patients. Four patients had a febrile UTI. Incidence of UTI in younger patients that underwent HBPD of UVJ is higher. Conclusion: Bacterial colonization is frequent in double-J stents but the incidence of UTI is low. Double-J colonization is higher in younger patients. Patients that underwent HPBD have a higher risk of UTI related with ureteral double J stent
Subject(s)
Humans , Male , Female , Child , Urinary Catheterization/adverse effects , Catheter-Related Infections/microbiology , Urinary Catheters/microbiology , Urinary Tract Infections/microbiology , Antibiotic ProphylaxisABSTRACT
La prevalencia de pacientes con sonda urinaria en el ámbito comunitario se ha cifrado entre el 0,02 y el 0,07%. A pesar del empleo sistemático de sistemas cerrados, el riesgo de bacteriuria tras la colocación de un catéter uretral oscila entre el 3 y el 10% por día, y su aparición es universal cuando la cateterización se prolonga durante 30 o más días. Aunque la mayor parte de estos episodios de bacteriuria son asintomáticos, hasta un 30% determinan síntomas clínicos y complicaciones, incluidas la sepsis grave y la muerte. Los organismos que infectan la orina de pacientes sometidos a cateterización uretral pertenecen con frecuencia a especies con menor sensibilidad a los antibióticos y constituyen biopelículas en ambas superficies del dispositivo así como, probablemente también, en el urotelio. La formación de biopelículas dificulta enormemente la erradicación con antibióticos de los microbios implicados, favorece posiblemente el desarrollo de resistencia y constituye en determinadas circunstancias el sustrato sobre el que se producen precipitados cristalinos que acaban obstruyendo la luz del dispositivo. Debido a la escasez de estudios clínicos controlados, existen todavía numerosas lagunas en el conocimiento de aspectos esenciales del manejo clínico del paciente portador de una sonda urinaria en la comunidad. En el presente artículo se revisan la epidemiología, los factores de riesgo, la microbiología, la patogenia, las manifestaciones clínicas, el diagnóstico, la prevención y el tratamiento de las infecciones asociadas al catéter urinario en el ámbito comunitario
The prevalence of urinary catheterization in the community ranges from 0.02% to 0.07%. Despite the generalized use of closed systems, the risk of bacteriuria in patients with urethral catheters is 3%-10% per day and its presence is universal when the device remains in place for 30 days or longer. Although most of these episodes of bacteriuria are asymptomatic, up to 30% of them lead to clinical symptoms and complications, including severe sepsis and death. The microorganisms infecting the urine of catheterized patients frequently belong to species less susceptible to antibiotics and form biofilms on both the device's surfaces and probably also on the urothelium. Biofilm formation greatly hampers eradication of the involved flora by antibiotics, probably favors the development of resistance and, in some instances, constitutes the substrate on which crystal precipitates are deposited, eventually resulting in blockage of the catheter lumen. Due to the scarce number of controlled studies, there are still many gaps in our knowledge of important issues concerning the clinical management of patients with indwelling urinary catheters in the community. The present study reviews the epidemiology, risk factors, microbiology, pathogenesis, clinical manifestations, diagnosis, prevention and treatment of catheter-related urinary tract infections in the community setting